Individuals with rare autoimmune rheumatic diseases have prominently increased risk for death versus general population
American Indians/Alaska Natives Have Elevated COVID-19 Mortality
Disparity between AI/AN and White individuals largest for those aged 20 to 49 years
FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine
Committee recommends emergency use authorization of the vaccine; vaccine to be distributed within 24 hours of EUA
Risk Factors for Severe COVID-19 Up in Cancer Survivors
Cancer survivors also have increased risk for influenza hospitalization/death compared with cancer-free controls
ED Visits for Peds Asthma Plunged Under COVID-19 Lockdown
Rate of emergency department visits decreased 80 and 82 percent in 2020 versus previous two years for week starting March 22
Neurologic Complications of COVID-19 Described
Most common neurologic findings in patients hospitalized for COVID-19 include altered mental status, fatigue, headache, stroke
FDA Authorizes First OTC COVID-19 Home Test Collection Kit
Last week, the agency also authorized an at-home test collection kit for COVID-19 and flu, available by prescription
Kidney Disease Leading Risk Factor for COVID-19 Hospitalization
COVID-19 patients with end-stage renal disease 11 times more likely to be hospitalized versus patients with no kidney disease
Live-Attenuated Virus Vaccine Development ‘is the Right Approach'
A vaccine biotech firm based in Massachusetts points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.
A live-attenuated virus is a weakened (attenuated) virus that is able to multiply within the host to a limited extent and engineered to be unable to cause any disease.
Live-Attenuated Virus Vaccine Development 'is the Right Approach'
A vaccine biotech firm based in Massachusetts points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.
A live-attenuated virus is a weakened (attenuated) virus that is able to multiply within the host to a limited extent and engineered to be unable to cause any disease.